ALGNAlign Technology
Price
+7.7%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, price roughly fair, growth steady, the market undecided.
Align Technology, Inc. (“we,” “us,” “our,” “Align” or the “Company”) is a global medical device company primarily engaged in the design, manufacture and marketing of Invisalign® clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (“GPs”), ViveraTM retainers for retention, iTeroTM intraoral scanners and services for dentistry, and exocadTM computer-aided design and computer-aided manufacturing (“CAD/CAM”) software for dental laboratories and dental practitioners.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Align Technology (ALGN) reported revenue of $1.06B in Q2 2026 (quarter ended Jun 30, 2026), up 4.3% from the same quarter a year earlier. That came with a gross margin of 72% and net income of $108M (10% of revenue). For the full year FY2025, revenue was $4.03B (+0.9% year on year) and net income $410M. Its largest segment in Q2 2026 was Clear Aligner at $871M, 82% of the disclosed total, well ahead of Systems And Services at 18%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 31, 2026Appointment of Quentin Blackford On August 27, 2026, the Board of Directors (the “Board”) of Align Technology, Inc. (the “Company”) appointed Quentin Blackford, 48, to the Board.Director or officer change · Form 8-K
- Jul 29, 2026Align Technology Announces Strategic Initiatives Consistent with Long-term Growth and Shareholder Value Creation Objectives.Regulation FD disclosure · press release
- Jul 9, 2026On July 6, 2026, Julie Coletti, Executive Vice President, Chief Legal and Regulatory Officer of Align Technology, Inc. (the “Company” ), resigned from the Company in order to join Illumina, Inc. as Chief Legal Officer.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $1.06BThe company’s own SEC segment disclosure.
- Clear Aligner$870.9M82%
- Systems And Services$185.3M18%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
The closest names by size in the same industry